AstraZeneca Launches Ecosystem-Focused Roadshow Recruitment in Respiratory, Cardiometabolic, and Oncology Fields

In the sunrise industry of healthcare, the moves of international giant AstraZeneca always serve as a significant bellwether.

From bolstering healthcare service capabilities to supporting early screening and diagnosis initiatives by associations at the county level; from exploring diverse pathways beyond traditional channels; and from innovation incubation to capital collaboration—AstraZeneca has shattered the stereotypical image of a traditional large pharmaceutical company. Leveraging its sponge-like capacity for learning, absorption, and innovative exploration, AstraZeneca harnesses ecosystem power to integrate diverse resources across government, industry, academia, research, healthcare, and investment sectors, fostering deep collaborations with partners in pharmaceuticals, medical devices, diagnostics, digitalization, and capital markets.

After five years of accumulation, AstraZeneca has revitalized itsChina Center for Intelligent Healthcare Innovation (CCiC), International Life Science Innovation Park (iCampus), and AstraZeneca CICC Healthcare Industry FundBy establishing an integrated innovative ecosystem, we have built a collaborative innovation platform that leverages strong resources from local governments, experts and scholars, industry leaders and innovative enterprises, top-tier investment institutions, and scientific research transformation platforms. This platform provides patients with higher-quality medical resources and services, while empowering enterprises with competitive advantages in the depth and breadth of resource access, thereby promoting deep integration and fission within the industrial ecosystem.

Against this backdrop,On August 5, 2022, the 5th AstraZeneca China Ecosystem Conference, themed “Convergence & Foresight,” will be grandly convened on the shores of Taihu Lake in Wuxi.

This conference will bring together industry leaders, high-growth companies, technical experts, and professional investors from both China and abroad in the life and health sectors to engage in multi-disciplinary industry discussions on chronic disease management, integrated oncology diagnosis and treatment, healthcare digitalization, innovative payment systems, and capital empowerment, with the aim of exploring the development of healthcare trends through reflection and practice.

Themed roadshows, as a key means for the AstraZeneca ecosystem to showcase its exchange and collaboration platform, will also be a highlight of the conference.This conference has specially arranged three themed roadshow sessions focusing on respiratory diseases, the “three highs” (hypertension, hyperglycemia, and hyperlipidemia), and oncology., providing a public showcase platform for outstanding healthcare innovation projects across China, and building a boundaryless communication bridge among stakeholders from government, industry, academia, research, healthcare, and investment sectors.

As a key segment of this year’s Ecosystem Conference,Therapeutic Areas of Metabolic Disorders, Respiratory Diseases, and OncologyThree Major Themed Roadshow Sessions Are Now Actively Recruiting Innovative Projects.

Through three dedicated roadshow sessions,AstraZeneca Aims to Build an Ecosystem Showcasing a Platform for Exchange and Collaboration, integrating cutting-edge industry insights, technological applications, in-depth resources, and corporate needs into a single platform to meet the demands for advanced technology dissemination, fostering an ecosystem for innovative enterprises, addressing clinical pain points, and sensing policy trends.

The dedicated roadshow session will provide a multi-dimensional analysis of the healthcare industry, covering perspectives from government, hospitals, universities, industry, and capital. At that time,Policy Experts and Scholarsor share insights on the current economic, policy, and regulatory environment;Academic Leader of Clinical MedicineAnalyze relevant needs and pain points from a clinical medicine perspective, and provide professional guidance and commentary on roadshow projects;Several Invited Industry-Leading FundsWill also engage in direct communication and negotiations with innovative projects;Healthcare InnovatorsSharing diverse solutions and case studies on the application of cutting-edge technologies. In summary, the three dedicated roadshow sessions aimed to ensure broad coverage and in-depth research across the fields of hypertension, hyperglycemia, hyperlipidemia (the “three highs”), respiratory diseases, and oncology by layering multiple perspectives to enhance cognitive understanding, thereby fostering healthy collaboration and exchange within the ecosystem.We welcome outstanding healthcare innovation projects to apply and join AstraZeneca as partners.

Respiratory Roadshow Special Session:Solutions for the field of interventional pulmonology;

Special Session on the "Three Highs" Roadshow:Innovative projects in the fields of solutions for diabetes, kidney disease, cardiovascular disease, hypertension, and obesity-related conditions, as well as foods for special medical purposes (FSMP);
Oncology Roadshow Special Session:Precision oncology diagnostics, digital therapeutics for cancer, and whole-course cancer management innovative projects (innovative solutions related to lung cancer, breast cancer, prostate cancer, ovarian cancer, and lymphoma are prioritized).

Innovation Ecosystem:Opportunity to become a core ecosystem partner of AstraZeneca, co-develop integrated diagnosis and treatment projects, and achieve commercial implementation;

Growth Potential:Opportunity to join the International Life Science Innovation Park (iCampus), with access to resources including space, funding, policy support, accelerator programs, cloud resources, mentorship, and commercialization networks;

Resource Network:Gain the opportunity to be housed in one of the six regional centers of the China Center for Intelligent Healthcare Innovation (CCiC), and secure opportunities to present your solutions to a diverse audience, including domestic and international dignitaries, medical experts, research institutions, investment firms, and professional media.

Funding Support:Access to evaluation and investment opportunities from the AstraZeneca CICC Healthcare Industry Fund and the iCampus Incubation Fund.

This is an opportunity for in-depth collaborative innovation with AstraZeneca. Project finalists willDelivered a thematic roadshow at the Medical Innovation Special Session of the 5th AstraZeneca China Ecosystem Conference, held in Wuxi, China on August 5.Finally, we sincerely invite you to participate in the roadshow recruitment for the AstraZeneca Ecosystem Conference, looking forward to working with you to find the optimal solutions for the healthcare industry.

Application Date:

From now until July 24, 2022

How to Participate:

Please scan the QR code below and complete the required information to register for the roadshow recruitment.

For any questions regarding event participation, please feel free to contact:icampus@astrazeneca.com